Xcout Intel
Golgenia
Golgenia is a research and development company operating in the drug discovery industry and advancing its GSL oncology platform. Headquartered in Milan, Italy, the company closed a 1.5 million euro Series A financing to support its pipeline toward first-in-human trials.
Subscribe to see Golgenia’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Golgenia at a glance
Golgenia is a biotech company headquartered in Italy. Its most recent funding round, Series A, raised $1.6M in July 2026. Xcout tracks 11 named people at Golgenia, including Khalid Islam, Ph.D. (Chairman and CEO).
Golgenia leadership
- Khalid Islam, Ph.D.Chairman and CEO
- Gianni LuiniChief Operating Officer
- Alberto Luini, M.D.Chief Scientific Officer
- Khalid IslamCEO and co-founder
- Alberto LuiniChief Scientific Officer and co-founder
- Fiorentino Izzoresearch and development
5 more named people on record for Golgenia, with roles, board committees and tenure — see the full roster →
Golgenia funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $1.6M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Golgenia news
Investors
Golgenia competitors
A few of Golgenia's closest competitors — see the full list of competitors and alternatives →
858 Therapeutics is a biotechnology and drug discovery company headquartered in San Diego, California, which recently raised a $50 million Series B financing.
Tolemy Bio is an AI-native virtual cell platform company with operations in Cambridge, United Kingdom, and Barcelona, Spain. The company focuses on virtual cell technologies for therapeutic development and manufacturing.
Pi Therapeutics is an Israeli preclinical-stage pharmaceutical company founded in 2015 and based in Ness Ziona. The company focuses on drug discovery and develops novel modulators of protein degradation for the treatment of cancer.
Sightera Biosciences is an Antwerp-based biotechnology startup leveraging clinically correlated patient data and an artificial intelligence platform to advance drug discovery and design.
Mironid Limited is a privately held drug discovery company founded in 2015 and headquartered in Glasgow, Scotland. The patient-focused company develops innovative therapeutics to improve the treatment of various medical conditions.
Cumulus Oncology operates Europe's first oncology biotech creation engine, identifying promising therapeutic assets and spinning out specialized companies. Headquartered in Edinburgh, Scotland, the company secured £9m in seed financing to accelerate its oncology drug development model. It employs a lean team dedicated to oncology asset creation.
Get Golgenia's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Golgenia in Xcout Intel
- 11 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access